Author: | Krug, L. M. |
Article Title: | An overview of chemotherapy for mesothelioma |
Abstract: | Effective chemotherapy for mesothelioma is currently available. Hopefully, it will provide a springboard for further advances, such as in the areas of targeted therapies and combined modality treatment because there remains a lot of room for improvement. © 2005 Elsevier Inc. All rights reserved. |
Keywords: | cancer chemotherapy; treatment outcome; clinical trial; fatigue; neutropenia; review; intensity modulated radiation therapy; sorafenib; cisplatin; doxorubicin; antineoplastic agents; capecitabine; gemcitabine; paclitaxel; methotrexate; temozolomide; topotecan; antineoplastic agent; carboplatin; unindexed drug; edema; bone marrow suppression; etoposide; gastrointestinal symptom; thrombocytopenia; granulocyte macrophage colony stimulating factor; cyclophosphamide; vincristine; ifosfamide; vinblastine; docetaxel; irinotecan; febrile neutropenia; drug delivery systems; drug mechanism; systematic review; cardiotoxicity; mitoxantrone; semaxanib; vatalanib; malignant mesothelioma; mesothelioma; mitomycin c; perioperative period; navelbine; drug dose regimen; folinate calcium; pemetrexed; meta analysis; peritoneum mesothelioma; raltitrexed; trimetrexate; razoxane; imidazole; edatrexate; amminedichloro(2 methylpyridine)platinum; ranpirnase |
Journal Title: | Hematology/Oncology Clinics of North America |
Volume: | 19 |
Issue: | 6 |
ISSN: | 0889-8588 |
Publisher: | Elsevier Inc. |
Date Published: | 2005-12-01 |
Start Page: | 1117 |
End Page: | 1136 |
Language: | English |
DOI: | 10.1016/j.hoc.2005.09.010 |
PUBMED: | 16325127 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Cited By (since 1996): 16" - "Export Date: 24 October 2012" - "CODEN: HCNAE" - "Source: Scopus" |